When cancer cells and platelets mix, the risk of metastasis and cancer-related deep vein thrombosis (DVT) and pulmonary embolism (PE) increases, but a small, proof-of-concept study suggests that the ...

Please provide your email address to receive an email when new articles are posted on . The study, which was presented at the virtual PCR e-Course and simultaneously published in Circulation, also ...

Extended P2Y12 inhibitor monotherapy beyond 12 months after percutaneous coronary intervention (PCI) reduces bleeding and ischemic events in acute coronary syndrome (ACS) patients at high risk for ...

Antiplatelet drugs are one of the main tools used to prevent thrombus formation in people who have had a heart attack or stroke or who have cardiovascular diseases with a high thrombotic risk. These ...

A recently recognized drug-drug interaction between opioids and P2Y12 inhibitors may have clinical implications for patients with ACS. Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is ...

Active ingredient: Ticagrelor 90 mg; tablets. Indication: To reduce the rate of thrombotic cardiovascular (CV) events in patients with acute coronary syndrome (ACS; unstable angina or non-ST-elevation ...